Literature DB >> 32468443

Microparticles (Exosomes) and Atherosclerosis.

Ya-Ting Chen1,2,3,4, Hao-Xiang Yuan1,2,3,4, Zhi-Jun Ou2,3,4,5, Jing-Song Ou6,7,8,9,10.   

Abstract

PURPOSE OF REVIEW: This review summarizes the effects of microparticles and exosomes in the progression of atherosclerosis and the prospect for their diagnostic and therapeutic potentials. RECENT
FINDINGS: Microparticles and exosomes can induce endothelial dysfunction, vascular inflammation, coagulation, thrombosis, and calcification via their components of proteins and noncoding RNAs, which may promote the progression of atherosclerosis. The applications of microparticles and exosomes become the spotlight of clinical diagnosis and therapy. Microparticles and exosomes are members of extracellular vesicles, which are generated in various cell types by different mechanisms of cell membrane budding and multivesicular body secretion, respectively. They are important physiologic pathways of cell-to-cell communication in vivo and act as messengers accelerating or alleviating the process of atherosclerosis. Microparticles and exosomes may become diagnostic biomarkers and therapeutic approaches of atherosclerosis.

Entities:  

Keywords:  Atherosclerosis; Exosomes; Extracellular vesicles; Microparticles; Microvesicles

Mesh:

Substances:

Year:  2020        PMID: 32468443     DOI: 10.1007/s11883-020-00841-z

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  18 in total

1.  Pentraxin 3 in Circulating Microvesicles: a Potential Biomarker for Acute Heart Failure After Cardiac Surgery with Cardiopulmonary Bypass.

Authors:  Yuan-Kai Song; Hao-Xiang Yuan; Yu-Peng Jian; Ya-Ting Chen; Kai-Feng Liang; Xiao-Jun Liu; Zhi-Jun Ou; Jia-Sheng Liu; Yan Li; Jing-Song Ou
Journal:  J Cardiovasc Transl Res       Date:  2022-07-25       Impact factor: 3.216

Review 2.  Role of Extracellular Vesicles in Autoimmune Pathogenesis.

Authors:  Wen-Cheng Wu; Sheng-Jiao Song; Yuan Zhang; Xing Li
Journal:  Front Immunol       Date:  2020-09-23       Impact factor: 7.561

Review 3.  Exosomes in atherosclerosis: performers, bystanders, biomarkers, and therapeutic targets.

Authors:  Chen Wang; Zhelong Li; Yunnan Liu; Lijun Yuan
Journal:  Theranostics       Date:  2021-02-15       Impact factor: 11.556

Review 4.  LKB1 Regulates Vascular Macrophage Functions in Atherosclerosis.

Authors:  Xuewen Wang; Ziwei Liang; Hong Xiang; Yanqiu Li; Shuhua Chen; Hongwei Lu
Journal:  Front Pharmacol       Date:  2021-12-15       Impact factor: 5.810

Review 5.  Dysfunctional Vascular Endothelium as a Driver of Atherosclerosis: Emerging Insights Into Pathogenesis and Treatment.

Authors:  Steven R Botts; Jason E Fish; Kathryn L Howe
Journal:  Front Pharmacol       Date:  2021-12-22       Impact factor: 5.810

Review 6.  Exosomes in Atherosclerosis, a Double-Edged Sword: Their Role in Disease Pathogenesis and Their Potential as Novel Therapeutics.

Authors:  Neil Patel; Deborah D Chin; Eun Ji Chung
Journal:  AAPS J       Date:  2021-07-26       Impact factor: 4.009

Review 7.  Prothrombotic state associated with preeclampsia.

Authors:  Cha Han; Yuan-Yuan Chen; Jing-Fei Dong
Journal:  Curr Opin Hematol       Date:  2021-09-01       Impact factor: 3.218

Review 8.  Potential Applications and Functional Roles of Exosomes in Cardiometabolic Disease.

Authors:  Sergio Ayala-Mar; Belén Rodríguez-Morales; Pedro Chacón-Ponce; José González-Valdez
Journal:  Pharmaceutics       Date:  2021-12-02       Impact factor: 6.321

Review 9.  Exosome-Based Treatment for Atherosclerosis.

Authors:  Jeongyeon Heo; Hara Kang
Journal:  Int J Mol Sci       Date:  2022-01-17       Impact factor: 5.923

10.  Circulating endothelial microparticles: a promising biomarker of acute kidney injury after cardiac surgery with cardiopulmonary bypass.

Authors:  Jian Ma; Hao-Xiang Yuan; Ya-Ting Chen; Da-Sheng Ning; Xiao-Jun Liu; Yue-Ming Peng; Chao Chen; Yuan-Kai Song; Yu-Peng Jian; Yan Li; Zui Liu; Zhi-Jun Ou; Jing-Song Ou
Journal:  Ann Transl Med       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.